lateral flow
Intelligent Fingerprinting Adding SARS-CoV-2 Saliva Test to Portfolio of Drug-Testing Assays
Premium
The company plans to launch its COVID-19 test in the early fall with CE marking and submit to the US Food and Drug Administration for Emergency Use Authorization.
Acquired by private equity investor Martis Capital last year, DCN completed two strategic acquisitions last month, and it is pursuing others.
Abingdon Health, BioSure UK Ink Manufacturing Deal for COVID-19 Lateral Flow Tests
Abingdon said it will manufacture BioSure’s COVID-19 lateral flow tests at Abingdon’s UK-based York and Doncaster sites.Â
Facing SEC Investigation, Chembio Diagnostics Reports 25 Percent Lift in Preliminary Q2 Revenues
The point-of-care diagnostics company also announced a $60M at-the-market sales agreement for shares of its common stock with the investment bank Craig-Hallum.
Global Access Health Acquires Rapid Test Firm Mologic; Invests at Least $41M in Deal
As part of the transaction Global Access Health will acquire all of Mologic's shares and integrate both Mologic and a sister entity, Global Access Diagnostics.
Mar 25, 2021
Mar 23, 2021
Jan 27, 2021